ENTA Operating Cash Flow (Statement)
Enanta Pharmaceuticals Inc · Operating Cash Flow (Statement)
ENTA Operating Cash Flow (Statement)
Latest reported-$35.32Mperiod ending
ENTA TTM Cash from Operations ($34.86M → -$35.32M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ENTA operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -35,316,000 | |
| -7,838,000 | |
| -14,170,000 | |
| -19,272,000 | |
| -23,183,000 | |
| -55,464,000 | |
| -70,577,000 | |
| -78,764,000 | |
| -89,966,000 | |
| -107,319,000 | |
| -92,501,000 | |
| -103,154,000 | |
| -97,086,000 | |
| -94,560,000 | |
| -107,152,000 | |
| -84,782,000 | |
| -90,269,000 | |
| -90,173,000 | |
| -68,377,000 | |
| -69,996,000 | |
| -64,436,000 | |
| -39,418,000 | |
| -20,165,000 | |
| 7,088,000 | |
| 31,094,000 | |
| 38,115,000 | |
| 53,527,000 | |
| 71,418,000 | |
| 91,214,000 | |
| 92,729,000 | |
| 55,065,000 | |
| 29,220,000 | |
| 58,185,000 | |
| 49,341,000 | |
| 53,917,000 | |
| 52,653,000 | |
| -6,779,000 | |
| -4,095,000 | |
| 8,961,000 | |
| 35,809,000 | |
| 35,560,000 | |
| 23,469,000 | |
| 112,276,000 | |
| 76,673,000 | |
| 74,116,000 | |
| 123,431,000 | |
| 20,440,000 | |
| 20,179,000 | |
| 22,608,000 | |
| -18,426,000 | |
| -4,263,000 | |
| 10,653,000 | |
| 11,454,000 | |
| 13,548,000 | |
| 34,856,000 | |
| 22,623,000 | |
| 20,685,000 |